{
    "Trade/Device Name(s)": [
        "STA\u00ae - Control LA 1+2",
        "STAR- Control LA 1+2"
    ],
    "Submitter Information": "Diagnostica Stago, Inc.",
    "510(k) Number": "K061803",
    "Predicate Device Reference 510(k) Number(s)": [
        "K952623"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "GGC",
        "GGN"
    ],
    "Summary Letter Date": "June 23, 2006",
    "Summary Letter Received Date": "June 27, 2006",
    "Submission Date": "June 22, 2006",
    "Regulation Number(s)": [
        "21CFR864.5425"
    ],
    "Regulation Name(s)": [
        "Plasma, Control, Normal & Abnormal"
    ],
    "Analyte Class(es)": [
        "coagulation",
        "immunology"
    ],
    "Analyte(s)": [
        "Lupus anticoagulant"
    ],
    "Specimen Type(s)": [
        "Plasma"
    ],
    "Specimen Container(s)": [
        "Citrate tube"
    ],
    "Instrument(s)/Platform(s)": [],
    "Method(s)/Technology(ies)": [],
    "Methodologies": [],
    "Submission Type(s)": [
        "Control"
    ],
    "Document Summary": "FDA 510(k) summary for STA\u00ae - Control LA 1+2 plasma control for lupus anticoagulant quality control in coagulation testing",
    "Indications for Use Summary": "Intended for quality control of tests for lupus anticoagulant detection using specified STA Staclot dRVV Screen, dRVV Confirm, and Staclot LA test kits",
    "fda_folder": "Hematology"
}